IOM Public Meeting, January 27, 2014: Part 3: Voice of the Patient, and ME/CFS …

Published March 10, 2014

IOM Public Meeting, January 27, 2014: Part 3: Voice of the Patient, and ME/CFS …

Filed under: drug abuse treatment outcome study

To provide background, Ms. Eggers explained that when the FDA reviews drugs for pre-market approval, it performs a risk/benefit assessment that takes into account a number of factors. …. Key message: The IOM study is important, because until we have …
Read more on ProHealth

Science of the Times: Group seeks change to drug development

Filed under: drug abuse treatment outcome study

The problem with all of this is that there might be benefits for patients in “unmonopolisable therapies” that drug companies don't look into for the simple reason that they aren't profitable. … If I'm GlaxoSmithKline, why would I spend hundreds of …
Read more on Delaware County Daily Times

Women Still Being Left Out of Medical Research: Report

Filed under: drug abuse treatment outcome study

Less than one-third of cardiovascular clinical trial participants are women, and only one-third of trials that include women report sex-specific outcomes. … "Unless you study the populations that you're treating, you really don't know how that …
Read more on Philly.com